Aspen Neuroscience, Inc.
ASPE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002124080
In the last 90 days, Aspen Neuroscience, Inc. insiders filed 3 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aspen Neuroscience, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 3 filings
- 3 insiders, $35.0M in total
- Open-market sells
- 0 filings
- Insiders trading
- 3
- Net value
- +$35.0M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aspen Neuroscience, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hasnain Faheem | Executive Chair | 348,330 | Nov 9, 2026 | 2 |
| Thompson Peter A. | Director, 10% Owner | 3,589,132Indirect | Nov 4, 2026 | 1 |
| OrbiMed Advisors LLC | Director, 10% Owner | 3,589,132Indirect | Nov 4, 2026 | 1 |
| OrbiMed Capital GP VII LLC | Director, 10% Owner | 3,589,132Indirect | Nov 4, 2026 | 1 |
| Crandell Keith | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| Nelsen Robert | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| Gillis Steven | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| Burow Kristina | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| ARCH Venture Fund X, L.P. | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| ARCH Venture Fund X Overage, L.P. | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| ARCH Venture Partners X Overage, L.P. | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| ARCH Venture Partners X, LLC | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| ARCH Venture Partners X, L.P. | 10% Owner | 1,200,000Indirect | Nov 2, 2026 | 1 |
| Berns Paul L | 10% Owner | 1,200,000 | Nov 2, 2026 | 1 |
| ARCH Venture Fund XIV, L.P. | 10% Owner | 1,200,000 | Nov 2, 2026 | 1 |
| ARCH Venture Partners XIV, L.P. | 10% Owner | 1,200,000 | Nov 2, 2026 | 1 |
| ARCH Venture Partners XIV, LLC | 10% Owner | 1,200,000 | Nov 2, 2026 | 1 |
| Spaventa Andrew | Director | 180,221Indirect | Nov 2, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2026 (view filing)6:47 PM ET | Nov 2 | 2 days | Thompson Peter A.Director, 10% Owner | PPurchase | +1.00M | $15.00 | +$15.0M | +38.6%3.59M after | Duplicate filing |
| Nov 4, 2026 (view filing)6:43 PM ET | Nov 2 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +1.00M | $15.00 | +$15.0M | +38.6%3.59M after | |
| Nov 2, 2026 (view filing)9:50 PM ET | Nov 2 | Same day | Crandell Keith and 8 others10% Owner | PPurchase | +133.3K | $15.00 | +$2.00M | New position66.7K after | 2 lots |
| Nov 2, 2026 (view filing)9:50 PM ET | Nov 2 | Same day | Crandell Keith and 8 others10% Owner | PPurchase | +1.20M | $15.00 | +$18.0M | New position1.20M after | Duplicate filing |
| Nov 2, 2026 (view filing)9:46 PM ET | Nov 2 | Same day | Berns Paul L and 3 others10% Owner | PPurchase | +1.20M | $15.00 | +$18.0M | New position1.20M after |